Remodeling of Human Osteochondral Defects via rAAV-Mediated Co-Overexpression of TGF-β and IGF-I from Implanted Human Bone Marrow-Derived Mesenchymal Stromal Cells.
IGF-I
TGF-β
hMSCs
osteochondral defect repair
rAAV vectors
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 Aug 2019
28 Aug 2019
Historique:
received:
03
08
2019
revised:
22
08
2019
accepted:
26
08
2019
entrez:
31
8
2019
pubmed:
31
8
2019
medline:
31
8
2019
Statut:
epublish
Résumé
The application of chondrogenic gene sequences to human bone marrow-derived mesenchymal stromal cells (hMSCs) is an attractive strategy to activate the reparative activities of these cells as a means to enhance the processes of cartilage repair using indirect cell transplantation procedures that may improve the repopulation of cartilage lesions. In the present study, we examined the feasibility of co-delivering the highly competent transforming growth factor beta (TGF-β) with the insulin-like growth factor I (IGF-I) in hMSCs via recombinant adeno-associated virus (rAAV) vector-mediated gene transfer prior to implantation in a human model of osteochondral defect (OCD) ex vivo that provides a microenvironment similar to that of focal cartilage lesions. The successful co-overexpression of rAAV TGF-β/IGF-I in implanted hMSCs promoted the durable remodeling of tissue injury in human OCDs over a prolonged period of time (21 days) relative to individual gene transfer and the control (reporter
Identifiants
pubmed: 31466339
pii: jcm8091326
doi: 10.3390/jcm8091326
pmc: PMC6781264
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Deutsche Arthrose-Hilfe e.V.
ID : MC
Références
Stem Cell Res Ther. 2016 Feb 01;7:20
pubmed: 26830674
Exp Cell Res. 1998 Jan 10;238(1):265-72
pubmed: 9457080
Curr Stem Cell Res Ther. 2015;10(2):121-31
pubmed: 25245889
Gene Ther. 2007 May;14(10):804-13
pubmed: 17344902
J Orthop Sports Phys Ther. 1998 Oct;28(4):192-202
pubmed: 9785255
Stem Cell Res Ther. 2012;3(3):22
pubmed: 22742415
Tissue Eng Part A. 2011 Aug;17(15-16):1921-33
pubmed: 21417714
Gene Ther. 2014 Sep;21(9):811-9
pubmed: 24989812
Osteoarthritis Cartilage. 2002 Jun;10(6):432-63
pubmed: 12056848
J Biol Chem. 2009 Mar 13;284(11):6697-704
pubmed: 19136669
J Bone Joint Surg Am. 1998 Dec;80(12):1795-812
pubmed: 9875939
Dtsch Arztebl Int. 2011 Oct;108(40):669-77
pubmed: 22114626
J Cell Biochem. 1994 Jan;54(1):85-99
pubmed: 8126089
J Virol. 1987 Oct;61(10):3096-101
pubmed: 3041032
J Transl Med. 2013 Sep 13;11:211
pubmed: 24034904
J Cell Biochem. 2006 Jan 1;97(1):33-44
pubmed: 16215986
Eur Cell Mater. 2008 Sep 03;16:26-39
pubmed: 18770504
J Biomed Mater Res A. 2015 Jan;103(1):371-83
pubmed: 24665073
Int J Mol Sci. 2019 May 27;20(10):null
pubmed: 31137788
J Virol. 1989 Sep;63(9):3822-8
pubmed: 2547998
Eur Cell Mater. 2007 May 31;13:93-9; discussion 99
pubmed: 17538898
Nat Rev Rheumatol. 2015 Apr;11(4):234-42
pubmed: 25776949
Mol Ther. 2005 Aug;12(2):229-38
pubmed: 16043094
Discov Med. 2016 Jun;21(118):495-506
pubmed: 27448786
Stem Cells Cloning. 2014 Jan 16;7:1-17
pubmed: 24520197
J Orthop Res. 1989;7(1):35-42
pubmed: 2642302
ACS Appl Mater Interfaces. 2016 Aug 17;8(32):20600-13
pubmed: 27404480
Am J Sports Med. 2018 Jul;46(8):1987-1996
pubmed: 29792508
Front Immunol. 2013 Oct 18;4:341
pubmed: 24151496
Tissue Eng Part C Methods. 2012 Jan;18(1):45-53
pubmed: 21875392
J Biomed Mater Res B Appl Biomater. 2010 Apr;93(1):164-74
pubmed: 20091911
Tissue Eng. 1998 Winter;4(4):415-28
pubmed: 9916173
Hum Gene Ther. 2014 Dec;25(12):1050-60
pubmed: 25333854
Stem Cell Res Ther. 2014 Aug 27;5(4):103
pubmed: 25163769